Vector Science & Therapeutics Announces Tommy Thompson as Chairman of the Board

Life Time Expands Phoenix Presence with April 30 Opening of 91,000-Square-Foot Paradise Valley Club at PV

Yale School of Medicine Receives $10 Million Gift to Fuel Support for Children's Mental Health and Emotional Well-Being

START Research Expands Clinical Leadership with Appointment of Dr. Neel Belani as Clinical Investigator at START New Jersey

Endometriosis Imaging Study Published in The Lancet Obstetrics, Gynaecology & Women's Health Highlights 99mTc-maraciclatide as a Promising Diagnostic and Monitoring Tool

ESTEVE'S EXPANSION AND GROWTH IN EU AND USA ACCELERATES ITS TRANSFORMATION INTO A GLOBAL HEALTHCARE COMPANY

Mercy Awarded Funding to Strengthen Care for Patients With Chronic High Blood Pressure

RedHill's RHB-204 Demonstrates Comparable MAP Killing Efficacy to RHB-104 - Important Step in RHB-204 Development for MAP-related Crohn's Disease

BD Achieves Excellence in Employee Well‑Being, Earning Top Industry Recognition

Cardinal Health Reports Third Quarter Fiscal Year 2026 Results and Raises Outlook

Capitan Orthopedics, Inc. Announces Breakthrough Device Designation for its SupraSpacer™ Implant

Oncura Health Continues Orange County Expansion with Anaheim Clinic Ribbon Cutting on May 6

Photon Raises $16M Series A to Give Patients Control Over Their Prescriptions and Bring Transparency to Pharmacy

IDEAYA Biosciences to Initiate New Drug Application Submission from the Darovasertib OptimUM-02 Trial under the Oncology Center of Excellence Real-time Oncology Review (RTOR) Program

Huahui Health and BeOne Medicines Enter into a Global Exclusive Option, License and Collaboration Agreement for Innovative Oncology Drug HH160

Demetra acquires Maxxspine Innovative GmbH, a company that has been a leader in advanced spinal solutions for over twenty years, further strengthening its position as a benchmark in spine surgery

Formosa Pharmaceuticals and Singapore Eye Research Institute (SERI) Partner to Advance Novel Ophthalmic Formulations for Corneal Diseases

2026 ESMO GC | Mabwell to Present Latest Clinical Data on 9MW2821 for Cervical Cancer in Oral and Poster Presentations

D3 Bio Presents KRAS Pipeline Updates at AACR 2026; Elisrasib (D3S-001), a Next-Generation KRAS G12C Inhibitor, Shows Strong Phase 2 Efficacy Across Multiple Tumor Types

CMEF 2026 wraps up in Shanghai: a global stage for medical breakthroughs and future trends

Ascletis to Present Data on Multiple Programs at the American Diabetes Association's 2026 Scientific Sessions

Phanes Therapeutics Announces Updated Phase 2 Clinical Trial Results of Spevatamig (PT886) in Combination with Chemotherapy in Frontline Treatment of Metastatic PDAC at the 2026 ASCO Annual Meeting

FDA approves label expansion, cementing TREMFYA® as the only IL‑23 inhibitor proven to help stop further joint damage

NEW VIRTUAL COMMUNITY ADVISORY BOARD SEEKS YOUNG ADULTS WITH EXPERIENCE IN THE CRIMINAL LEGAL SYSTEM

Sysmex America Introduces Next Generation XR-Series™ Hematology Solution for Clinical Laboratories

MediOps Launches MediOps Aviation for Time-Critical Medical Missions

Generate Biomedicines Inc. to Participate in Goldman Sachs 47th Annual Global Healthcare Conference

Bausch Health's Aesthetic Business, Solta Medical, Earns Prestigious Trademark Certification of Thermage® in China

Whitehawk Therapeutics to Present at the Jefferies 2026 Global Healthcare Conference

Aetna launches Aetna Mental Health On Demand to provide real time access to care and ongoing support